ea0073aep479 | Pituitary and Neuroendocrinology | ECE2021
Giuca Diandra Carmen
, Trifanescu Raluca
, Vere Cristin Constantin
, Baciu Ionela
, Baculescu Nicoleta
, Capatina Cristina
, Dusceac Roxana
, Găloiu Simona Andreea
, Niculescu Dan Alexandru
, Radian Serban
, Caragheorgheopol Andra
, Schipor Sorina
, Poiana Catalina
BackgroundProlactinomas are the most frequent type of hormone-secreting pituitary adenomas. Prolactin(PRL)-receptor mediates intracellular signaling pathways that contribute to weight gain, dyslipidemia, impaired fasting glucose (IFG), type 2 diabetes mellitus (T2DM) and cardiovascular disease, parameters that improve along with PRL level control on dopamine agonist (DA) therapy.AimTo assess metabolic disturb...